Biogen (BIIB)
(Delayed Data from NSDQ)
$234.13 USD
+4.33 (1.88%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $234.87 +0.74 (0.32%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Brokerage Reports
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 661 - 680 ( 803 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Our View on ENDEAR and the Nusinersen Opportunity
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Buying Back Shares Is Good, Buying New Assets Is Better
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Anti-LINGO Miss May Be a Catalyst for Growth-Oriented BD
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
2016 Digestive Disease Week Recap
Provider: Rodman & Renshaw, Co.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
2016 Digestive Disease Week Recap
Provider: H.C. Wainwright & Co., Inc.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Unearthing Gems in the Promised Land: An Overview of the Israeli Life Sciences Sector
Provider: H.C. Wainwright & Co., Inc.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Unearthing Gems in the Promised Land: An Overview of the Israeli Life Sciences Sector
Provider: Rodman & Renshaw, Co.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Emerging Themes from AAN: Cognitive Resilience in Alzheimer?s and Multiple Sclerosis
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Long-term Alzheimer?s Strategy Remains Strong; Reit Buy Rating and $360 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A